Document is current
Any future updates will be listed below
-
Authors
Singaram, Indira
Sharma, Ashutosh
Pant, Shashank http://orcid.org/0000-0002-8222-3616
Lihan, Muyun
Park, Mi-Jeong
Pergande, Melissa http://orcid.org/0000-0003-1197-4057
Buwaneka, Pawanthi http://orcid.org/0000-0002-2650-6208
Hu, Yusi
Mahmud, Nadim
Kim, You-Me http://orcid.org/0000-0001-8780-704X
Cologna, Stephanie
Gevorgyan, Vladimir http://orcid.org/0000-0002-7836-7596
Khan, Irum
Tajkhorshid, Emad
Cho, Wonhwa http://orcid.org/0000-0003-1410-2481
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R35GM122530)
- License Information
-
More Information
Article History
Received: 27 September 2021
Accepted: 25 August 2022
First Online: 13 October 2022
Competing interests
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. S.P. is currently an employee of Loxo Oncology @ Lilly and is a shareholder of stock in Eli Lilly and Co.
